Literature DB >> 15208751

Recurrent vomiting and persistent gastroesophageal reflux caused by unrecognized constipation.

Stephen M Borowitz1, James L Sutphen.   

Abstract

Over a 2-year period, 34 children were referred to the division of pediatric gastroenterology at the University of Virginia with chronic upper gastrointestinal symptoms whose symptoms rapidly and completely resolved when their unrecognized constipation was treated. The average age at presentation was 8.24 (SD 0.78) years and average duration of upper intestinal symptoms was 15.6 (SD 3.5) months. Twenty-six of 34 had experienced recurrent vomiting, 6 complained of chronic nausea, 17 had chronic symptoms of gastroesophageal reflux, and 20 complained of chronic or recurrent abdominal pain, most often in the epigastric region. Smaller numbers had experienced early satiety, choking, gagging, dysphagia, or intermittent diarrhea. Given the prevalence of constipation in childhood, it seems likely that many children who experience chronic upper intestinal symptoms may be suffering from chronic unrecognized constipation as the cause of their upper intestinal symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208751     DOI: 10.1177/000992280404300507

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

1.  Growth and nutritional risk in children with developmental delay.

Authors:  C Malone; F Sharif; C Glennon-Slattery
Journal:  Ir J Med Sci       Date:  2015-11-16       Impact factor: 1.568

2.  Treatment options in pediatric GERD.

Authors:  Neelesh A Tipnis; Colin D Rudolph
Journal:  Curr Treat Options Gastroenterol       Date:  2007-10

3.  Co-occurrence of childhood functional constipation and gastroesophageal reflux disease (GERD).

Authors:  Shokoufeh Ahmadipour; Aysan Salami-Khaneshan; Fatemeh Farahmand; Parastoo Baharvand
Journal:  Ann Med Surg (Lond)       Date:  2022-01-29

4.  Gastric emptying of water in children with severe functional fecal retention.

Authors:  V P I Fernandes; M C L Lima; E E Camargo; E F Collares; J M Bustorff-Silva; E A Lomazi
Journal:  Braz J Med Biol Res       Date:  2013-03-15       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.